MELISSA HUTZLER: Open Payments
NPI 1346553898 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,207 in 156 payments from 19 companies in 2025. Trend: 2023 $2,635 · 2024 $3,032 · 2025 $3,207
Food & beverage: $2,457Consulting: $750
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 1 | $750 |
| GENZYME CORPORATION | 14 | $476 |
| Janssen Biotech, Inc. | 30 | $348 |
| ABBVIE INC. | 26 | $326 |
| Lilly USA, LLC | 15 | $224 |
| UCB, Inc. | 20 | $198 |
| Galderma Laboratories, L.P. | 17 | $192 |
| LEO Pharma Inc. | 8 | $169 |
| Organon LLC | 4 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
Products named: DUPIXENT, TREMFYA, RINVOQ, Bimzelx, NEMLUVIO, EBGLYSS, ADBRY, TALTZ.
Industry payments across PA — which companies pay providers there.
